Synthesis of <sup>13</sup>C‐Labeled Pyrazinone Thrombin Inhibitors and Elucidation of Metabolic Activation Pathways
Jonathan Z. Ho, David G. Melillo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Matthew P. Braun, Raju Subramanian(Gilead Sciences (United States)), Dennis Dean(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ying‐Duo Gao(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 4
Related Papers
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325
Comparison of Information-Dependent Acquisition, SWATH, and MS<sup>All</sup> Techniques in Metabolite Identification Study Employing Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry
|Analytical Chemistry|2013|211
Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry
|Journal of Mass Spectrometry|2006|153
Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors
|Journal of Medicinal Chemistry|2011|120